Drug Trial Radar · NCT06668792
An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma
Last checked: Nov 19, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Dec 26, 2024
Primary completion
Feb 2026
Study completion Jul 2028
Sponsor
- Lead sponsor
- BiocadIndustry
- Sponsor type
- Industry
- First posted
- Oct 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to assess the efficacy and safety of BCD-248 as a therapy for relapsing and/or refractory multiple myeloma.
Conditions
- Relapsed/Refractory Multiple Myeloma
Interventions
BCD-248Drug
subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall response rate according to IMWG (International Myeloma Working Group) criteriaTime frame: Up to 24 weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
SBHI of the Kaliningrad region "Central City Clinical Hospital"
Kaliningrad, Russia · Not yet recruiting
SAHI "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigala"
Kazan', Russia · Not yet recruiting
FSBI of science "Kirov research Institute of Hematology and blood transfusion of the Federal medical and biological Agency"
Kirov, Russia · Not yet recruiting
Regional Government-Owned Publicly Funded Healthcare Institution "Regional Clinical Hospital"
Krasnoyarsk, Russia · Recruiting
Branch of the limited liability company "Hadassah Medical LTD"
Moscow, Russia · Recruiting
City Clinical Hospital №52 of the Department of Health of the City of Moscow
Moscow, Russia · Recruiting
FSBI "National Medical Research Center of Oncology named after N. N. Blokhin" of the Ministry of Health of the Russian Federation
Moscow, Russia · Not yet recruiting
JSC "Medsi Group of Companies"
Moscow, Russia · Recruiting
SBI of health care of the city of Moscow city clinical hospital named after S. P. Botkin of the Department of health of the City of Moscow
Moscow, Russia · Not yet recruiting
State budgetary healthcare Institution of the Moscow Region "Moscow Regional Research Clinical Institute named after M. F. Vladimirsky"
Moscow, Russia · Not yet recruiting
Federal State Budgetary Institution "National Medical Research Center for Radiology" of the Ministry of Health of the Russian Federation
Obninsk, Russia · Not yet recruiting
SBHI of the Republic of Karelia "Republican Hospital named after V.A. Baranov"
Petrozavodsk, Russia · Not yet recruiting
FSBI "Almazov National Medical Research Centre" of the Ministry of Health of the Russian Federation
Saint Petersburg, Russia · Recruiting
FSBEI of Higher Education "Samara State Medical University" of the Ministry of Health of the Russian Federation
Samara, Russia · Not yet recruiting
FSBEI HE "Saratov State Medical University named after V.I. Razumovsky" of the Ministry of Health of Russia
Saratov, Russia · Recruiting
Private healthcare institution "Clinical hospital "RZD-Medicine" of the city of Smolensk"
Smolensk, Russia · Not yet recruiting
State Budgetary Healthcare Institution "Oncological Dispensary No.2" of the Ministry of Health of the Krasnodar Region
Sochi, Russia · Not yet recruiting
Public institution "Komi Republican cancer clinic"
Syktyvkar, Russia · Recruiting
FSBEI of Higher Education "Bashkir State Medical University" of the Ministry of Health of the Russian Federation
Ufa, Russia · Not yet recruiting
State budgetary healthcare institution of the Sverdlovsk region "Sverdlovsk regional clinical hospital №1"
Yekaterinburg, Russia · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.